Evidence map›Paper›PMID 31191482›Full record

ArticleFrontiers in microbiology2019

Gina Paola Rodriguez-Castaño, Matthew R Dorris, Xingbo Liu, Bradley W Bolling, Alejandro Acosta-Gonzalez, Federico E Rey

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Functional changes in the gut microbiota are associated with the intestinal phenotype in A20 haploinsufficiency.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2026
    Article
  8. Article
  9. Saliva-driven surface-engineeredBioactive materials · 2026
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Gina Paola Rodriguez-CastañoGrupo de Investigacion en Bioprospeccion (GIBP), Facultad de Ingenieria, Universidad de La Sabana, Chía, Colombia.
Matthew R DorrisDepartment of Food Science, University of Wisconsin-Madison, Madison, WI, United States.
Xingbo LiuDepartment of Food Science, University of Wisconsin-Madison, Madison, WI, United States.
Bradley W BollingDepartment of Food Science, University of Wisconsin-Madison, Madison, WI, United States.
Alejandro Acosta-GonzalezGrupo de Investigacion en Bioprospeccion (GIBP), Facultad de Ingenieria, Universidad de La Sabana, Chía, Colombia.
Federico E ReyDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI, United States.
University of Wisconsin–Madison · USUniversidad de La Sabana · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Consumption of flavonoids has been associated with protection against cardiovascular and neurodegenerative diseases. Most dietary flavonoids are subjected to bacterial transformations in the gut where they are converted into biologically active metabolites that are more bioavailable and have distinct effects relative to the parent compounds. While some of the pathways involved in the breakdown of flavonoids are emerging, little it is known about the impact of carbon source availability and community dynamics on flavonoid metabolism. This is relevant in the gut where there is a fierce competition for nutrients. In this study, we show that metabolism of one of the most commonly consumed flavonoids, quercetin, by the gut-associated bacterium

Indexed as

Bacteroides thetaiotaomicronbutyratecross-feedingEubacterium ramulusquercetin degradationstarch

Identifiers

PMID31191482
PMCPMC6548854
OpenAlexW2947074052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.